These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2352989)

  • 1. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Clough JD; Lewis EJ; Lachin JM
    Prog Clin Biol Res; 1990; 337():301-7. PubMed ID: 2352989
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Lan SP; Rohde RD; Lachin JM
    N Engl J Med; 1992 May; 326(21):1373-9. PubMed ID: 1569973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis for lupus nephritis. Lupus Plasmapheresis Study Group.
    Euler HH; Schroeder JO
    N Engl J Med; 1992 Oct; 327(14):1028; author reply 1029-30. PubMed ID: 1518539
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmapheresis for lupus nephritis.
    Wallace DJ
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518541
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis for lupus nephritis.
    Sesso R; Klag M
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518540
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis for lupus nephritis.
    Robinson JA
    N Engl J Med; 1992 Oct; 327(14):1028-9; author reply 1029-30. PubMed ID: 1472252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis].
    Saracyn M; Korsak J; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):162-4. PubMed ID: 15603328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of lupus nephritis. A two-year prospective study.
    Doria A; Piccoli A; Vesco P; Vaccaro E; Marson P; De Silvestro G; Ossi E; Gambari P
    Ann Med Interne (Paris); 1994; 145(5):307-11. PubMed ID: 7985937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
    J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of long-term immunotherapy in patients with lupus nephritis].
    Zitnan D; Lukác J; Rovenský J
    Vnitr Lek; 1989 Feb; 35(2):137-44. PubMed ID: 2711621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
    Lewis EJ
    J Clin Apher; 1992; 7(3):153. PubMed ID: 1286995
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Pohl MA; Lan SP; Berl T
    Ann Intern Med; 1991 Jun; 114(11):924-9. PubMed ID: 2024858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus nephropathy. II. Treatment].
    Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 1989 May; 81(5):309-15. PubMed ID: 2697869
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
    Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
    Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.